Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Pharmaceutical corporations by U.S. revenue 2018
Top 10 pharmaceutical corporations by U.S. revenue in 2018 (in billion U.S. dollars)
Pharmaceutical corporation Pizer generated some 25.3 billion U.S. dollars in revenue within the United States in 2018. This statistic shows the top 10 pharmaceutical corporations by revenue generated in the United States only during 2018.
Top 10 pharmaceutical corporations by U.S. revenue in 2018 (in billion U.S. dollars)
| Revenue in billion U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Revenue in billion U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Please be patient - this may take a moment
Description
Source
More information
- Show sources information
- Show publisher information
- Release date
- March 2019
- Region
- United States
- Survey time period
- 2018
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- March 2019
More information
- Region
- United States
- Survey time period
- 2018
- Open this statistic in...
Other statistics on the topic
Pharmaceutical Industry in the U.S.
+Pharmaceutical Products & Market
World pharmaceutical sales 2016-2018 by region
+Pharmaceutical Products & Market
Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
+Pharmaceutical Products & Market
Pfizer's total revenue 2006-2018
+Pharmaceutical Products & Market
Johnson & Johnson's total revenue 2005-2018
You only have access to basic statistics.
This statistic is not included in your account!
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate solution including all features.
Prices do not include sales tax.
All Information
in one Presentation
- 99 page/s
- English
- pptx
- Detailed references
Everything On "U.S. pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
- Contribution to global pharma
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*World pharmaceutical market distribution by submarket 2014-2018
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*World pharmaceutical sales 2016-2018 by region
- Market share of top 10 national pharmaceutical markets worldwide in 2017*Market share of the leading 10 global pharmaceutical markets 2017
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2019*Leading countries in life sciences sector M&As 2019
- Overview
- Total nominal spending on medicines in the U.S. from 2002 to 2018 (in billion U.S. dollars)*U.S. total medicine spending 2002-2018
- Top 20 U.S. therapy areas based on drug spending in 2018 (in billion U.S. dollars)Leading therapy areas for U.S. drug spending 2018
- Top 20 prescription drugs based on U.S. sales in 2018 (in billion U.S. dollars)*U.S. top 20 prescribed drugs based on sales 2018
- Top 20 U.S. pharma products by dispensed prescriptions in 2018 (in millions)Top U.S. pharma products by prescriptions 2018
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2018 (in billion U.S. dollars)Pharmaceutical channel distribution by U.S. spending 2014-2018
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Companies
- 2019 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*2019 list of top U.S. biotech and pharmaceutical companies based on revenue
- Top 10 pharmaceutical corporations by U.S. revenue in 2018 (in billion U.S. dollars)Pharmaceutical corporations by U.S. revenue 2018
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)Pfizer's total revenue 2006-2018
- Johnson & Johnson's total revenue from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's total revenue 2005-2018
- AbbVie's revenue from 2010 and 2018 (in million U.S. dollars)AbbVie's revenue 2010-2018
- Research and development
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2018 (in billion U.S. dollars)*Research and development expenditure: U.S. pharmaceutical industry 1995-2018
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2018U.S. pharma industry R&D spending as a percent of total revenues 1990-2018
- Number of biopharma medicines in development in the U.S. as of April 2019, by therapeutic category*Pharmaceuticals: biopharma medicines in development in 2019, by category
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*Pharmaceuticals: cost of drug development in the U.S. since 1975
- Total number of novel drugs approved by CDER from 2008 to 2018Number of novel drugs approved annually by CDER 2008-2018
- Annual number of accepted orphan designations in the United States from 2003 to 2018Number of orphan designations accepted in the U.S. 2003-2018
- New medicine brands spending growth in the U.S. from 2014 to 2018 (in billion U.S. dollars)U.S. sales growth of new brand medicines 2014-2018
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2001-2015R&D expenditure per employee in U.S. sectors 2001-2015
- Generics
- Top generic drug companies by unbranded generics revenue in the U.S. in 2016-2017 (in billion U.S. dollars)*Unbranded generics revenue top corporations in U.S. 2016-2017
- Change in branded and generic medication spending in the United States from 2013 to 2018 (in billion U.S. dollars)*Spending change on branded and generic medicines in the U.S. 2013-2018
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2018U.S. brand and generic prescription drug revenue 2005-2018
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2018Branded vs. generic U.S. drug prescriptions dispensed 2005-2018
- Savings through generic drug usage in the United States from 2008 to 2018 (in billion U.S. dollars)Savings through generic drug usage in the U.S. 2008-2018
- Actual and projected decrease in U.S. brand drug spending due to loss of exclusivity from 2013 to 2023 (in billion U.S. dollars)Projected decrease in brand drug spending due to patent loss in the U.S. 2013-2023
- Outlook
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2022
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*Top branded biologic drugs in the U.S. that will go generic by 2028
- Projected top 10 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)Leading U.S. pharmaceutical products by revenue 2024
- Projected 2024 revenue for selected top drugs approved in the U.S. in 2018 (in million U.S. dollars)Projected 2024 revenue for top drugs approved U.S. 2018
- Projected cannabinoid-based pharmaceuticals market size in the U.S. from 2020 to 2029 (in billion U.S. dollars)*U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection
- The consumer's view
- How is your overall impression of the U.S. pharma industry?U.S. adults impression of the U.S. pharma industry
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?U.S. adults that believe physicians are under pressure from pharma to prescribe drugs
- How would you rate the U.S. pharma companies concerning the quality of their drugs?U.S. adults impression of the U.S. pharma drug qualities
- How would you rate the U.S. pharma companies concerning their fairness towards patients?U.S. adults impression of the U.S. pharma companies fairness towards patients
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017U.S. adults who would rate selected pharma features as excellent or good 2017
- Which of these pharma companies do you prefer when buying drugs?Preferred pharma companies by Americans for drug purchase 2017
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*Americans on US pharma quality compared to foreign pharma 2017
- Pharmaceutical corporations by U.S. market share 2016
- Pharmaceutical corporations by U.S. sales 2010
- Top 50 pharmaceutical companies by prescription sales and R&D spending 2012
- Fuji Pharma's operating profit FY 2013-2018
- Prescription drug advertising in the U.S. 2010-2014
- Fuji Pharma's sales composition FY 2018, by therapeutic category
- Number of companies in the pharmaceutical industry in France 1970-2016
- Fuji Pharma's total assets FY 2013-2018
- Fuji Pharma's net sales FY 2013-2018
- Most advertised prescription drugs in the U.S. in 2017, by print ad spending
- Fuji Pharma's net sales composition FY 2018, by therapeutic category
- Fuji Pharma's net income FY 2013-2018
- Fuji Pharma's R&D costs FY 2013-2018
- Business risks at selected pharmaceutical companies 2011
- Lease expenses of selected U.S. pharmaceutical companies 2011 and 2016
- Systemic hormonal preparations pharmaceutical consumption in Spain 2004-2017
- United Kingdom (UK): pharmaceutical products export value to Greece 2012-2018
- GDP from manufacture of chemicals, pharmaceuticals and botanical Indonesia 2014-2018
- Latin America: viral inactivation revenue 2018-2023
- Most commonly used subsidized prescription drugs Australia 2015
- Pharmaceutical trends in Europe
- Indicatori Farmaceutici
- Pharmaceutical industry in Italy
- Sobi Anual and sustainability report 2017
- Pharmaceutical industry in India
- Pharmaceutical industry in Japan
- Pharmaceutical industry in China
- Vaccine industry in China
- Biotechnology in Germany
- Generic Pharmaceutical Industry Yearbook 2016
- Teva - 2018 Form 10-K
- Novo Nordisk ANNUAL REPORT 2017
- Great Expectations: Why Pharma Companies Can’t Ignore Patient Services
- 2019 PhRMA Annual Membership Survey
- California Life Sciences Industry Report 2019
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
- Demographics
- Economy
- Education & Science
- Politics & Government
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
As a Premium user you get access to the detailed source references and background information about this statistic.
As a Premium user you get access to background information and details about the release of this statistic.
As soon as this statistic is updated, you will immediately be notified via e-mail.
As soon as this statistic is updated, you will immediately be notified via e-mail.
You need at least a Premium Account to use this feature.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.